Having trouble viewing this email? View in your browser.

Thermo Fisher Scientific
Join Thermo Fisher Scientific at ECCMID 2024, 27-30 April in Barcelona, Booth C9
Register now
Let us help empower your expertise at ECCMID 2024 with innovative solutions to fight antimicrobial resistance (AMR), perform molecular testing for infectious disease pathogens, and guide effective outcomes.

Stop by Booth C9 to see our latest solutions for antimicrobial susceptibility testing (AST) and molecular diagnostic testing for microbial and viral pathogen detection. Plus:

Thermo Fisher Scientific
Register for our Innovation & Pipeline Theater events:
  • Critical results for critical samples
    Federico Pea, MD, FISAC Full Professor of Pharmacology, Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Italy;
    Head SSD Clinical Pharmacology - Dept. Integrated Management of Infectious Risk University Hospital IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy
  • Development and implementation of a customised rapid syndromic test for severe pneumonia
    Dr Andrew Conway Morris, MBChB(hons), BSc(hons), PhD, MRCP, FRCA, FFICM, MRC Clinician Scientist, University of Cambridge, Hon Consultant in Intensive Care Medicine, Addenbrookes Hospital, Cambridge, Mackintosh Professor, Royal College of Anaesthetists
  • New solutions for nucleic acid detection using 1-step RT-qPCR
    Agnė Žiupkaitė, Product Manager, Custom Commercial Supply, Thermo Fisher Scientific

And, visit our scientific posters:
  • Clinical performance evaluation of a real-time PCR-based test for the detection of high-risk HPV genotypes
  • Comparison of AI-assisted and manual interpretation of disc diffusion test from 12 antibiotics of Pseudomonas aeruginosa
  • Enhancing pathogen detection in viral respiratory tract infections among individuals aged>55 years through expanded PCR panel testing
  • Performance evaluation of an expanded PCR panel for uropathogen identification in urinary tract infections compared to standard urine culture
  • Evaluation of the equivalency of the Oxoid aztreonam/avibactam (30/20 μg) antimicrobial susceptibility testing disc to the CLSI M07 broth microdilution frozen reference method
  • Evaluation of the Oxoid imipenem/relebactam (10/25 µg) antimicrobial susceptibility testing (AST) disc against the predicate AST disc

See the schedule of events and what’s in the booth »
Products are distributed globally so uses, applications, and availability of product in each country depend on local regulatory marketing authorization status. 

© 2024 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified. We hereby disclose that this email communication is for commercial purposes.

View our privacy policy.

Thermo Fisher Scientific
168 Third Avenue
Waltham, MA 02451
United States
Thermo Fisher Scientific

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.